Peptide Atlas · Peptide

Exenatide

Exenatide (exendin-4) is an incretin mimetic studied for glycemic control in type 2 diabetes.

established

provisional
PubChem 45588096
3 citations
0 discussions
0 followers
AC2993
Bydureon
Byetta
Exendin-4

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 3 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Exenatide. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
30-week randomized trial in metformin-treated type 2 diabetes	established	pmid 15855572
EXSCEL cardiovascular outcomes trial	established	pmid 28910237
Exendin-4 increases beta-cell mass in diabetic rats	preclinical	pmid 10580413

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.